Arcturus Therapeutics Holdings Inc (ARCT)
27.21
+0.42
(+1.57%)
USD |
NASDAQ |
May 10, 16:00
27.21
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Price to Book Value: 2.776 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.733 |
| May 08, 2024 | 2.776 |
| May 07, 2024 | 2.812 |
| May 06, 2024 | 2.787 |
| May 03, 2024 | 2.782 |
| May 02, 2024 | 2.705 |
| May 01, 2024 | 2.847 |
| April 30, 2024 | 2.608 |
| April 29, 2024 | 2.716 |
| April 26, 2024 | 2.708 |
| April 25, 2024 | 2.670 |
| April 24, 2024 | 2.752 |
| April 23, 2024 | 2.849 |
| April 22, 2024 | 2.760 |
| April 19, 2024 | 2.650 |
| April 18, 2024 | 2.684 |
| April 17, 2024 | 2.819 |
| April 16, 2024 | 3.073 |
| April 15, 2024 | 2.989 |
| April 12, 2024 | 3.103 |
| April 11, 2024 | 3.318 |
| April 10, 2024 | 3.247 |
| April 09, 2024 | 3.228 |
| April 08, 2024 | 3.154 |
| April 05, 2024 | 3.26 |
| Date | Value |
|---|---|
| April 04, 2024 | 3.120 |
| April 03, 2024 | 3.338 |
| April 02, 2024 | 3.285 |
| April 01, 2024 | 3.373 |
| March 31, 2024 | |
| March 28, 2024 | 3.264 |
| March 27, 2024 | 3.176 |
| March 26, 2024 | 3.105 |
| March 25, 2024 | 3.362 |
| March 22, 2024 | 3.276 |
| March 21, 2024 | 3.202 |
| March 20, 2024 | 3.204 |
| March 19, 2024 | 3.262 |
| March 18, 2024 | 3.202 |
| March 15, 2024 | 3.509 |
| March 14, 2024 | 3.515 |
| March 13, 2024 | 3.663 |
| March 12, 2024 | 3.739 |
| March 11, 2024 | 3.662 |
| March 08, 2024 | 3.562 |
| March 07, 2024 | 3.594 |
| March 06, 2024 | 3.651 |
| March 05, 2024 | 3.630 |
| March 04, 2024 | 3.638 |
| March 01, 2024 | 3.827 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.446
Minimum
Mar 22 2023
70.31
Maximum
May 22 2020
6.207
Average
3.374
Median
Aug 15 2022
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.108 |
| Perspective Therapeutics Inc | 13.66 |
| Protalix BioTherapeutics Inc | 2.416 |
| Electromed Inc | 3.658 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.571 |
| Price to Free Cash Flow | 74.43 |
| Price | 27.21 |
| Earnings Yield | -14.37% |
| Market Cap | 732.81M |